More regulation will likely lead to slower and more limited access to drugs.
access to medicines
Canadians can also expect tax hikes to pay for the government drug program.
In a bid to get even steeper drug discounts, Health Canada recently proposed changes to our reference-pricing system.
Ottawa’s changes may delay the launch of new innovative medications in Canada.
Under Medicare in the U.S., private insurers compete to offer coverage within regions.
National Pharmacare appears to be regarded by many as a panacea for the woes of the present hodgepodge of provincial drug plans, but some provinces seem to view it as an opportunity to alleviate the strain on their drug budgets.